Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

Vanderbilt Researchers Identify Protein's Possible Role in Chemotherapy Resistance

David Cortez, Ph.D.

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

The protein, RADX, is a DNA-binding protein. It regulates the activity of an enzyme called RAD51, which helps repair tumor-promoting DNA breaks and ensure an accurate copy of the DNA is made during cell division. RAD51, in turn, is gathered up and transported to the sites of DNA damage and DNA replication by the BRCA2 protein.

Mutations in the BRCA2 gene disrupt the DNA repair and replication functions of the BRCA2/RAD51 pathway, increasing the risk of cancers of the breast, ovaries, prostate and pancreas as well as melanoma.

Since BRCA2 mutations also reduce the ability of tumor cells to repair broken DNA, these cells are sensitive to DNA-damaging anti-cancer drugs like cisplatin and newly approved DNA repair inhibitors like Olaparib. If the cells acquire secondary mutations that restore normal BRCA2 function, however, they can become resistant to the drugs.

This is the case with ovarian cancer. Within six months one quarter of ovarian tumors will become resistant to cisplatin. Only a third of patients survive beyond five years, making ovarian cancer the fifth-leading cause of cancer death among women in the United States.

RADX, the protein discovered by the Vanderbilt scientists, may be a key to understanding and overcoming this resistance.

In a paper published in the journal Molecular Cell, David Cortez, Ph.D., and colleagues describe how RADX regulates the activity of RAD51 in a way that promotes genome stability and modulates drug sensitivity.

Much remains to be learned. But if, as suspected, RADX determines how tumors respond to therapy, it could be a target for efforts to overcome resistance, the researchers concluded.

The paper's first authors were Huzefa Dungrawala, Ph.D., a postdoctoral fellow in Cortez's lab, and graduate student Kamakoti Bhat. Cortez is Ingram Professor of Cancer Research and professor of Biochemistry and co-leader of the Genome Maintenance Program in the Vanderbilt-Ingram Cancer Center.

The research was supported in part by National Institutes of Health grants GM116616, CA092584, CA212435 and GM118089.


Related Articles:

Recent Articles

Physicians Discuss Opioids, Scope of Practice and More During TMA Annual Meeting

State's Largest Professional Organization for Doctors Announces 2018-2019 Officers

Read More

Tristar Centennial Medical Center Announces Construction Of New Multi-Level Parking Garage

Tristar Centennial Medical Center is pleased to announce the construction of a new multi-level parking garage that will be located at the corner of 23rd Avenue and Patterson Street.

Read More

Healthcare Redesigned

Nature and sustainability are key in today's updated medical facilities.

Read More

McWhorter Society Luncheon Honors Healthcare Luminaries

The annual McWhorter Society Luncheon at Belmont University celebrated healthcare accomplishments by honoring Gov. Winfield C. Dunn and announcing the 2018 inductees into the Tennessee Health Care Hall of Fame.

Read More

Mazzetti+GBA Launches Tool for Healthcare Architects, Engineers

A new app unveiled in Nashville by Mazzetti+GBA supports project planning for healthcare architects, engineers

Read More

Making Medical Devices Lighter, Stronger, Safer

Locally company Can-Do National Tape is using their expertise in adhesives to make medical device and design lighter, stronger, safer.

Read More

NMGMA: 10 Minute Takeaway

You can't manage what you can't measure ... KraftCPA's Lucy Carter shares the basic principles of medical office accounting.

Read More

Insights from Inside the Beltway

As EBG celebrates their first anniversary in Nashville, senior strategists from the firm's D.C. office share insights from the nation's capital.

Read More

Physician Spotlight: TennCare CMO Victor Wu

TennCare CMO launches programs aimed at improving health of Tennessee's Medicaid recipients.

Read More

Making the Grade

Men's Health Report card shows improvement in key markers.

Read More

Email Print



Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: